Neurogenic stunned myocardium;Aturdimiento miocárdico neurogénico

Medicina Intensiva

Volumn 30, Issue 1, 2006, Pages 13-18

  Ruiz Bailen M ^a,c   Rucabado Aguilar, L ^a   Lopez Martinez A ^b  

^a Hospital Universitario Medico Quirurgico   (Spain)

^b HOSPITAL DE PONIENTE   (Spain)

^c NONE   (Spain)

Author keywords

Brain hemorrhaging; Cranioencephalic traumatism; Myocardial dysfunction; Stunned myocardium

Indexed keywords

BIOLOGICAL MARKER;

ANGIONEUROTIC EDEMA; BRAIN DEATH; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL DISEASE; NEUROLOGIC DISEASE; ORGAN DONOR; PROGNOSIS; REVIEW; STUNNED HEART MUSCLE; SURVIVAL; BRAIN HEMORRHAGE; BRAIN INJURY;

BRAIN INJURIES; HUMANS; INTRACRANIAL HEMORRHAGES; MYOCARDIAL STUNNING;

EID: 33644768086     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(06)74456-4     Document Type: Review

References (45)

1. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-9.
2. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609-34.
3. Hollenberg SM, Parrillo JE. Reversible causes of severe myocardial dysfunction. J Heart Lung Transplant. 1997;16:S7-12.
4. Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. Chest. 1998;114:98-105.
5. Iga K, Hori K, Kitaguchi K, Matsumura T, Gen H, Tomonaga G, et al. Transient segmental asynergy of the left ventricle of patients with various clinical manifestations possibly unrelated to the coronary artery disease. Jpn Cir J. 1991;55:1061-7.
6. Ruiz Bailen M. Reversible myocardial dysfunction in critically ill, non-cardiac patients: a review. Crit Care Med. 2002;30:1280-90.
7. Ruiz Bailen M, Aguayo de Hoyos E, López Martínez A, Díaz Castellanos MA, Ruiz Navarro S, Fierro Roson LJ, et al. Reversible myocardial dysfunction, a possible complication in critically ill patients without heart disease. J Crit Care. 2003;18:245-52.
8. Burch GE, Myers R, Abildskov JA. A new electrocardiographic pattern observed in cerebrovascular accidents. Circulation. 1954;9:719-23.
9. Seiler C, Laske A, Gallino A, Turina M, Jenni R. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant. 1992;11:867-74.
10. Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol. 1999;84:578-82.
11. Delgado C, Rubert C, Barturen F. Myocardial stunning in the context of a subarachnoid hemorrhage. Rev Esp Cardiol. 1998;51:840-3.
12. Pollick C, Cujee B, Parker S. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12:600-5.
13. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24:636-40.
14. Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13:774-9.
15. Mayer SA, LiMandri G, Sherman D, Lennihan L, Fink ME, Solomon RA, et al. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg. 1995;83:889-96.
16. Deibert E, Aiyagari V, Diringer MN. Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation. Heart. 2000;84:205-7.
17. Kuroiwa T, Morita H, Tanabe H, Ohta T. Significance of ST segment elevation in electrocardiograms in patients with ruptured cerebral aneurysms. Acta Neurochir (Wien). 1995;133:141-6.
18. Mayer SA, Fink ME, Homma S, Sherman D, LiMandri G, Lennihan L, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44:815-20.
19. Sato K, Masuda T, Izumi T. Subarachnoid hemorrhage and myocardial damage clinical and experimental studies. Jpn Heart J. 1999;40:683-701.
20. Tzung-Dau W, Chau-Chung W, Yuan-Teh L. Myocardial stunning after cerebral infarction. Int J Cardiol. 1997;58:308-11.
21. Ohtsuka T, Hamada M, Kodama K, Sasaki O, Suzuki M, Hara Y, et al. Neurogenic stunned myocardium. Circulation. 2000;101:2122-4.
22. Baroldi G, Di Pasquale G, Silver MD, Pinelli G, Lusa AM, Fineschi V. Type and extent of myocardial injury related to brain damage and its significance in heart transplantation: a morphometric study. J Heart Lung Transplant. 1997;16:994-1000.
23. Zhu W, Olson DE, Karon BL, Tajik AJ. Myocardial stunning after electroconvulsive therapy. Ann Intern Med. 1992;117:914-5.
24. Bernstein R, Mayer SA, Magnano A. Neurogenic stunned myocardium in Guillain-Barre syndrome. Neurology. 2000;54:759-62.
25. Chuang CP, Chao CL. Neurogenic stunned myocardium in a patient with metastatic brain tumors. Int J Cardiol. 2000;76:251-3.
26. Troll GF, Dohrmann GJ. Anaesthesia of the spinal cord-injured patient: cardiovascular problems and their management. Paraplegia. 1975;13:162-71.
27. Huttemann E, Schelenz C, Chatzinikolaou K, Reinhart K. Left ventricular dysfunction in lethal severe brain injury: impact of transesophageal echography on patient management. Intensive Care Med. 2002;28:1084-8.
28. Horowitz MB, Willer D, Keffer J. The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 1998;140:87-93.
29. Deehan SC, Grant LS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Med. 1996;22:672-6.
30. Bulsara KR, McGirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98:524-8.
31. Oppenheimer S, Cechetto D. Cardiac chronotropic organization of the rat insular cortex. Brain Res. 1990;533:66-72.
32. Yuki K, Kodama Y, Onda J, Emoto K, Morimoto T, Uozumi T. Coronary vasospasm following subarachnoid haemorrhage as a cause of stunned myocardium. Case report. J Neurosurg. 1991;75:308-11.
33. Herijgers P, Nishimura Y, Flameng W. Endothelial activation through brain death? J Heart Lung Transplant. 2004;23: S234-9.
34. Francis J, Zhang ZH, Weiss RM, Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2004;287:H791-7.
35. Abe T, Morgan DA, Gutterman DD. Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation. Am J Physiol. 1997;272:H25-34.
36. Dujardin KS, McCully RB, Wijdicks EF, Tazelaar HD, Seward JB, McGregor CG, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Transplant. 2001;20:350-7.
37. Szabo G. Physiologic changes after brain death. J Heart Lung Transplant. 2004;23:S223-6.
38. Samuels MA. Neurogenic heart disease: a unifying hypothesis. Am J Cardiol. 1987;60:15J-9.
39. Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35:548-51.
40. Novitzky D, Cooper DK, Morrell D, Isaacs S. Changes from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation. 1988;45:32-6.
41. Seiler C, Laske A, Gallino A, Turina M, Jenni R. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant. 1992;11:867-74.
42. Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol. 1999;84:578-82.
43. Kappelle LJ, Van Der Worp HB. Treatment or prevention of complications of acute ischemic stroke. Curr Neurol Neurosci Rep. 2004;4:36-41.
44. Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2004;25:126-9.
45. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737-42.